CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
Cincinnati Financial Corporation Share Price Target ‘$119.14’, now 6.4% Upside Potential 30 January 2024
Palantir Technologies Inc. Share Price Target ‘$15.14’, now -11.4% Downside Potential 30 January 2024
International Flavors & Fragrances Inc. Share Price Target ‘$82.96’, now 1.2% Upside Potential 30 January 2024
Capital One Financial Corporation Share Price Target ‘$138.00’, now -.3% Downside Potential 30 January 2024
Alnylam Pharmaceuticals, Inc. Share Price Target ‘$225.48’, now 24.6% Upside Potential 30 January 2024
CQS Natural Resources Growth & Income Fund: Why Energy Scarcity and M&A Are Driving the Next Commodities Boom (Video) 11 February 2026
Norcros plc offers “considerable upside” as acquisitions strengthen growth, highlights fund manager (LON:NXR) 9 February 2026
SYNCONA LIMITED ORD NPV (SYNC.L): Analyst Consensus Points to Over 100% Upside Potential 12 February 2026
Supermarket Income REIT PLC ORD (SUPR.L) Rating Update: Exploring the 7.36% Dividend Yield and Growth Potential 12 February 2026
SOFTCAT PLC (SCT.L) Investor Outlook: Evaluating a 55.76% Potential Upside in the Tech Sector 12 February 2026
SSP Group PLC (SSPG.L) Stock Analysis: Navigating a 25.81% Upside in the Competitive Restaurant Sector 12 February 2026
Spire Healthcare Group (SPI.L) Stock Analysis: With a 32.95% Upside, Is This UK Medical Care Giant a Buy? 12 February 2026
